Important information regarding cookies and
By using this website, you consent to the use of cookies in accordance with the IMB Cookie Policy. For more information on cookies, see our Cookie Policy.
Full Version | Search

The Irish Medicines Board -

IMB Logo

Rimcazole Clinical Trial at Shandon Clinic – IMB Report

03 October 2011

The Irish Medicines Board (IMB) has today published the findings of its investigation into the conduct of a clinical trial using rimcazole hemifumarate at the Shandon Clinic in August 2010.

This investigation was initiated by the IMB after three subjects participating in the trial experienced seizures. All three subjects recovered fully when the administration of the trial medication was discontinued.

The IMB is the competent authority for the regulation of medicines in Ireland. It is a statutory function of the IMB to assess applications from sponsors to conduct clinical trials.

IMB Rimcazole Trial Report

Date Printed: 16 April 2014

© Irish Medicines Board 2014 | Developed by Engine Solutions

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971